Patent classifications
A61K33/16
PHOSPHATE CROSSLINKED STARCH NANOPARTICLE AND DENTAL TREATMENTS
A phosphorous compound such as STMP is used as a cross-linking agent while making a starch nanoparticle in an emulsion process. Negative charge of the nanoparticle is reduced or reversed by adding cations and/or cationizing the starch optionally while forming the nanoparticles. Anionic active agents, such as fluoride or fluorescein, are optionally incorporated into the nanoparticle during the formation process. For example, a fluoride salt can also be used, which promotes the crosslinking reaction while also providing fluoride in the nanoparticle. The retention of both calcium and fluoride in the nanoparticle is improved when both salts are used. Alternatively, the nanoparticle may be used without added calcium and/or fluoride. The nanoparticles may be useful for tooth remineralization, the treatment of dentinal hypersensitivity, to treat caries, or as a diagnostic agent to locate carious lesions.
PHOSPHATE CROSSLINKED STARCH NANOPARTICLE AND DENTAL TREATMENTS
A phosphorous compound such as STMP is used as a cross-linking agent while making a starch nanoparticle in an emulsion process. Negative charge of the nanoparticle is reduced or reversed by adding cations and/or cationizing the starch optionally while forming the nanoparticles. Anionic active agents, such as fluoride or fluorescein, are optionally incorporated into the nanoparticle during the formation process. For example, a fluoride salt can also be used, which promotes the crosslinking reaction while also providing fluoride in the nanoparticle. The retention of both calcium and fluoride in the nanoparticle is improved when both salts are used. Alternatively, the nanoparticle may be used without added calcium and/or fluoride. The nanoparticles may be useful for tooth remineralization, the treatment of dentinal hypersensitivity, to treat caries, or as a diagnostic agent to locate carious lesions.
ANTIBACTERIAL MOUTHRINSE COMPOSITION COMPRISING PROBOSCIDEA JUSSIEUI
A mouthrinse composition comprising an ethanolic extract of Proboscidea jussieui leaves with a concentration between 0.7% (w/v) and 1.3% (w/v), a fluoride component with a concentration between 0.02% (w/v) and 0.08% (w/v), and propylene glycol with a concentration between 0.7% (w/v) and 1.3% (w/v).
ANTIBACTERIAL MOUTHRINSE COMPOSITION COMPRISING PROBOSCIDEA JUSSIEUI
A mouthrinse composition comprising an ethanolic extract of Proboscidea jussieui leaves with a concentration between 0.7% (w/v) and 1.3% (w/v), a fluoride component with a concentration between 0.02% (w/v) and 0.08% (w/v), and propylene glycol with a concentration between 0.7% (w/v) and 1.3% (w/v).
Aqueous oral care iodide-containing compositions, methods, and kits
An aqueous oral care one-part composition (e.g., solution), a kit that includes such composition (e.g., solution), and methods (e.g., a method of providing fluoride to a patient's tooth surface), wherein the oral care composition (e.g., solution) includes: silver cations; iodide anions; fluoride anions; and water.
PROTEIN HYDROLYSATES
The present invention provides marine protein hydrolysates for use in pharmaceuticals, nutraceuticals functional foods, foods, beverages, and animal feeds, as well as methods for making marine protein hydrolysates.
PROTEIN HYDROLYSATES
The present invention provides marine protein hydrolysates for use in pharmaceuticals, nutraceuticals functional foods, foods, beverages, and animal feeds, as well as methods for making marine protein hydrolysates.
SILVER FLUORIDE SOLUTIONS FOR DENTAL COMPOSITIONS
The present invention relates to an aqueous Silver Fluoride (AgF) containing solutions with pH 4.0-5.3.
BUFFERED MICROENCAPSULATED COMPOSITIONS AND METHODS
A microcapsule composition comprising at least one polymer substantially disposed as a semipermeable shell around an aqueous buffered solution and at least one agent, wherein the agent permeates the shell, and wherein the composition is suitable for delivery to a mammal.
BUFFERED MICROENCAPSULATED COMPOSITIONS AND METHODS
A microcapsule composition comprising at least one polymer substantially disposed as a semipermeable shell around an aqueous buffered solution and at least one agent, wherein the agent permeates the shell, and wherein the composition is suitable for delivery to a mammal.